Purchase Order 12505B19P0063
Award Date 9/9/19
Potential Completion Date 12/31/19
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lexington, KY 40505, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for $301,894.16 in firm fixed-price services related to testing lead compounds for additional characterization and reagent development. The contract does not have a set-aside designation. Eurofins Discoverx Corporation is a provider of innovative cell-based...
- This is a federal contract award from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Eurofins Discoverx LLC, a foreign-owned for-profit organization based in Fremont, California. The contract, which does not have a set-aside designation, is for stable cell line screening services to support compound discovery research. The fixed-price contract has a ceiling value of $24,985.40 and an ultimate completion date of December 30,...
- The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $20,830.00 firm-fixed-price purchase order to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, for the provision of PATHHUNTER CHO-K1 DRD3 ARRESTIN CELL LINE and U2OS DRD3 ARRESTIN CELL LINE. This award is not associated with any set-aside program. Eurofins Discoverx Corporation is a leading provider of innovative cell-based assays...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed-price purchase order valued at $20,787.00 to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for the provision of the PATHHUNTER CHO-K1 DRD2L (LONG ISOFORM) ARRESTIN cell line, which is used in drug discovery and development research. Eurofins Discoverx is a leading provider of innovative cell-based...
- This federal contract award, valued at $17,895.60, was issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned, for-profit organization. The contract was awarded on a firm fixed-price basis without any set-aside designations. Eurofins Discoverx Corporation, which specializes in providing innovative cell-based assays, reagents, and services to support...
- This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The $22,869.00 firm fixed-price purchase order was awarded to Eurofins Discoverx LLC, a foreign-owned for-profit organization that specializes in providing cell-based assays, reagents, and services to support drug discovery and development research. The purpose of this contract is to conduct a kinase panel screening of 25 small...
- This is a $19,386.28 firm fixed-price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency under the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for assaying services to support NIAAA's research activities, with a completion date of August 27, 2024. Eurofins Discoverx Corporation is a provider of cell-based assays, reagents, and services for drug...
- The National Institutes of Health (NIH) awarded a $75,705.70 firm fixed-price purchase order contract to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, to provide PathHunter cell lines, reagents, and kits. The contract supports the Therapeutics for Rare and Neglected Diseases (TRND) program at the National Center for Advancing Translational Sciences (NCATS) within the NIH. The requested products will be used to develop dopamine D3 receptor antagonists for the...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 22 (VISN 22), a civilian agency within the U.S. Department of Veterans Affairs, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The $17,740.00 contract is for EUROFINS PANELING SERVICE, with a period of performance ending on February 28, 2025. Eurofins Discoverx Corporation is a well-established provider of cell-based assays, reagents, and services supporting drug discovery...
- The federal contract award is for $300,609.00 and was granted to Eurofins Discovery Services North America, LLC, a foreign-owned, for-profit contract research organization. The award is a delivery order under a larger indefinite delivery vehicle (IDV) contract with the National Institute on Drug Abuse (NIDA), a part of the U.S. Department of Health and Human Services. The contract is for receptor profiling and predictive toxicology services, specifically receptor binding studies, safety...